started · updated
Medical AI and Incheon Sejong Hospital present smartwatch heart failure screening results
At the American Heart Association Scientific Sessions 2026, Seoul-based Medical AI and Incheon Sejong Hospital presented findings from the WATCH-LV study regarding AI-driven heart failure screening. The model uses 30-second ECG recordings from smartwatches to detect left ventricular systolic dysfunction, defined by an ejection fraction of 40 percent or less.
The study demonstrated high accuracy across different devices, achieving an area under the ROC curve of 0.907 for the Apple Watch and 0.895 for the Galaxy Watch. In a cohort of 2,211 adults, the systems showed comparable overall accuracy, though calibration thresholds differed between the devices.
To address the clinical burden of false positives, researchers implemented a decision rule requiring positive results on at least two out of three days. In a second group of 108 outpatient patients, this approach significantly reduced false alarms. Further randomized studies are planned to confirm the effectiveness of the model in daily use.
Entities
American Heart Association · Apple Watch · Galaxy Watch · Incheon Sejong Hospital · Medical AI